Hereditary hemorrhagic telangiectasia: An informative review

• Main Authors: Neha Rajpurohit, Piyush Kumar Bharbey, M Jatin, Khayati Moudgil
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2020-01-01
• Series: Iraqi Journal of Hematology
• Subjects: abnormalities; bleeding; blood vessels; hemorrhagic; life-threatening
• Online Access: http://www.ijhonline.org/article.asp?issn=2072-8069;year=2020;volume=9;issue=2;spage=55;epage=60;aulast=Rajpurohit

Inherited hemorrhagic telangiectasia (HHT or Osler–Weber–Rendu syndrome) is a hereditary condition characterized by malformations of multiple blood vessels (vascular dysplasia), which may lead to bleeding (hemorrhaging). Chronic nosebleeds are often the first warning, and malformations in various blood vessels can lead to abnormalities in the lungs, brain, spinal cord, and liver. There are a number of therapies available for various aspects of HHT to improve the quality of life and avoid life-threatening complications. Individuals with HHT have an almost average life expectancy. HHT is inherited as a dominant autosomal trait. We have done this review to enlighten the scientific fraternity about HHT. In this review, we have tried to explain about HHT and its related management.